Avivagen Announces Closing of Additional $1.75 Million Private Placement
(World News Science)

Ottawa, ON /Business Wire/ January 27, 2020 / - Avivagen Inc. (TSXV:VIV) (`Avivagen` or the `Company`), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce the successful second and final closing of its previously announced non-brokered private placement (the `Offering`). In connection with this final closing Avivagen has issued 3,500,000 units (the `Units`) at an issue price of $0.50 per Unit for aggregate gross proceeds to the Company of $1,750,000. With the proceeds of the first closing which occurred on January 2, 2020, this closing brings the total gross proceeds of the Offering to...